This article will explore whether Testicular cancer can cause low testosterone in men. In the case of men, it has been shown that a cancerous tumor in the testicles can suppress the production of testosterone. Regenics (for Testosterone Therapy may cause hypogonadism. However, a man with this disease can still conceive and reproduce.
Testicular cancer causes hypogonadism
Hypogonadism is a male disorder caused by problems in the pituitary gland or hypothalamus. In men, the pituitary gland secretes two hormones – gonadotropin-releasing hormone (GHRH) and luteinizing hormone (LH). These hormones stimulate the testes to produce testosterone. When the levels of these hormones are low, sperm and testosterone production are affected.
Survivors of testicular cancer are at increased risk for hypogonadism, and if untreated, it may negatively affect their long-term health. Approximately twelve to eighteen percent of testicular cancer patients experience long-term hypogonadism. via Regenics can lead to a wide range of problems, including cardiovascular disease, diabetes, and lowered sperm production.
Treatments for this condition may result in an increase in serum levels of luteinizing hormone. While most survivors recover from this condition and experience a full-time sperm production, some men experience hypogonadism after treatment. However, treatment for hypogonadism can improve quality of life and reduce the risk of many adverse health outcomes, such as diabetes, hyperlipidemia, and early cardiac problems.
In https://www.google.com/maps?cid=3424385977669420479 of men with TGCC, 38.5% had hypogonadism at diagnosis. This condition was defined as a serum testosterone level of three ng/mL or lower. The study also showed that the risk of hypogonadism increased with age, body mass index, and level of vigorous activity.
A recent analysis of 143 patients with TGCC found a higher risk of hypogonadism after radiation or chemotherapy. However, the study did not include men who had undergone more than two cycles of combined therapy or those who had been treated with three or four cycles of high-dose chemotherapy.
Symptoms of hypogonadism after puberty include hot flashes, irregular menstruation, and decreased energy. There are several lifestyle changes that can be made to increase or maintain testosterone levels. The normal range for testosterone is 300 to 1,000 nanograms per deciliter. When the levels are lower, the condition is called compensated hypogonadism.
Inflammatory markers are also associated with hypogonadism. High inflammatory markers like IL-6 increase the risk of hypogonadism. Inflammation increases subcutaneous fat and inhibits testicular function. When testosterone is not produced, the body’s metabolism is unable to keep up with the hormone levels.
Fortunately, there are effective treatments for testicular tumor. Platinum-based chemotherapy improves the 10-year survival rate of patients with testicular cancer. However, chemotherapy can cause problems with the Leydig cells, which is a key part of the sperm maturation process. In addition, chemotherapy increases the risk of cardiovascular events, metabolic syndrome, and diabetes.
Treatment for testicular cancer can also cause hypogonadism. However, most men regain their fertility within a few months after the cancer treatment. In many cases, treatment with radiation or chemotherapy may interfere with the production of testosterone. However, if a man has already begun treatment, preserving his sperm before cancer treatment is necessary may help him regain fertility.
Hypogonadism is a common symptom among testicular cancer survivors. It can be caused by a number of factors, including genetic abnormalities and medication. A significant number of men with testicular cancer have low testosterone, which can affect other aspects of their health. For these reasons, clinicians must ask patients about their symptoms and monitor the patient for any signs of associated health problems.
18133 Ventura Blvd Suite C, Tarzana, CA 91356